Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022
Sun, March 6, 2022
Fri, March 4, 2022
Thu, March 3, 2022
Wed, March 2, 2022

Drew Ranieri Maintained (TMCI) at Buy with Decreased Target to $28 on, Mar 4th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-28-on-mar-4th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Buy with Decreased Target from $30 to $28 on, Mar 4th, 2022.

Drew has made no other calls on TMCI in the last 4 months.



There is 1 other peer that has a rating on TMCI. Out of the 1 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Drew


  • Danielle Antalffy of "SVB Leerink" Maintained at Buy with Decreased Target to $32 on, Friday, November 5th, 2021